| 3/27/2025 | BK | Market Commentary: Novolex, Fairbanks, Interstate Waste break; Paradigm updated; Opella, Grain accelerated
|
| 3/27/2025 | BKCVDDEMIGPV | Market Commentary: Mohegan deal crosses finish line; Hertz reverses downtrend; junk funds lose $110 million
|
| 3/27/2025 | BK | Novolex shifts funds between term loans, firms at SOFR plus 325 bps
|
| 3/25/2025 | BK | Market Commentary: Bausch Health, M6 Midstream break; CohnReznick, Vista Global modified; Novolex accelerated
|
| 3/24/2025 | BKCVDDEMIGPV | Market Commentary: EZCorp drives-by; Novolex joins calendar; XPLR improves; Dun & Bradstreet pops
|
| 3/17/2025 | BK | Market Commentary: BRG breaks; Valvoline, Tacala accelerated; Novolex, M6, EnergySolutions, Red Oak set talk
|
| 3/17/2025 | BKDDGNHY | Moody's ups Novolex, rates loans, notes B2
|
| 3/17/2025 | BKDDGNHY | Fitch rates Clydesdale loan, debt BB+, BB
|
| 3/17/2025 | BKDDGNHY | S&P ups Novolex, rates loan, notes B+
|
| 3/17/2025 | BK | Novolex launches $2.91 billion of term loans at SOFR plus 325-350 bps
|
| 3/14/2025 | BK | Market Commentary: Potomac Energy term loan breaks atop OID; Pursuit Aerospace tables loan transaction
|
| 3/14/2025 | BK | Novolex readies launch of new term loan B for Monday
|
| 12/13/2024 | BKDDGNHY | Moody’s views Clydesdale positively
|
| 12/10/2024 | BKDDGNHY | S&P adds Clydesdale to positive watch
|
| 12/9/2024 | BK | Novolex obtains financing commitments for Pactiv Evergreen acquisition
|
| 7/25/2024 | BK | Novolex firms $2.44 billion term loan at SOFR plus 325 bps
|
| 7/24/2024 | BKGNHY | S&P rates Clydesdale notes B
|
| 7/24/2024 | BKGNHY | Moody's assigns B2 to Novolex notes
|
| 7/22/2024 | BK | Market Commentary: MedRisk breaks; Garda updated; HUB, Graham, Novolex, Envu, Austin, Apex and MJH set talk
|
| 7/22/2024 | BK | Novolex launches $2.44 billion term loan at SOFR plus 325-350 bps
|
| 1/24/2024 | BK | Market Commentary: Ahead DB, Dun & Bradstreet, Caesars, Merlin Entertainments, Tricor/Vistra, Novolex break
|
| 1/23/2024 | BK | Novolex finalizes $2.96 billion term loan at 99.75 OID
|
| 1/17/2024 | BK | Market Commentary: Parexel, Ryan, International SOS, MKS, Idemia, Conservice break; Imperial, 1-800 revised
|
| 1/17/2024 | BK | Novolex launches $2.96 billion term loan at SOFR plus 375 bps
|
| 4/8/2022 | BKCVDDEMIGPV | Market Commentary: Oldcastle on deck; secondary closes volatile week on soft footing; Earthstone Energy at a premium
|
| 4/1/2022 | BKCVDDEMIGPV | Market Commentary: In junk bonds, Talen in focus on potential bankruptcy filing; Novolex improves; Yum! weakens
|
| 3/31/2022 | BKCVDDEMIGPV | Market Commentary: Junk secondary closes volatile quarter quietly; Novolex, Churchill at a premium; Talen dives
|
| 3/30/2022 | BK | Market Commentary: Novolex term loan frees to trade atop OID; Solenis accelerates commitment deadline
|
| 3/30/2022 | BK | Novolex lifts term loan to $3 billion, revises OID to 97.5
|
| 3/29/2022 | BKCVDDEMIGPV | Market Commentary: Junk secondary rallies on cease-fire optimism; EQT upgraded; Nielson jumps on buyout
|
| 3/28/2022 | BKCVDDEMIGPV | Market Commentary: Presidio adds-on; Novolex on deck; Plantronics spikes on buyout; YUM! improves
|
| 3/21/2022 | BKDDHY | S&P gives Novolex, loans, notes B, notes CCC+
|
| 3/21/2022 | BK | Market Commentary: Forefront Dermatology tweaks loan commitment deadline; Novolex comes to market
|
| 3/21/2022 | BKDDHY | Moody’s rates Novolex loans B2, notes B2, Caa2
|
| 3/21/2022 | BK | Novolex launches $2.63 billion term loan at SOFR plus 425 bps
|
